Potentials of incretin-based therapies in dementia and stroke in type 2 diabetes mellitus.

J Diabetes Investig · 2016 · PMC4718099 · PMID 26816596

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Combined pre‐ and post‐treatment with peripherally‐administered linagliptin in diabetic rodents showed a trend toward a decrease in infarct volume 118 .

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.